National Organization for Rare Disorders, Inc.
It is possible that the main title of the report Macular Degeneration is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.
- Foveal Dystrophy, Progressive
- Macula Lutea, degeneration
- Macular Dystrophy
- Tapetoretinal Degeneration
- Behr 1
- Behr 2
- Adult Macula Lutea Retinae Degeneration
- Presenile Macula Lutea Retinae Degeneration
- Stargardt's Disease (STGD)
- Juvenile Macular Degeneration
- Macular Degeneration, Senile
- Macular Degeneration, Disciform
Macular degeneration is a degenerative disease affecting the macula or center of the retina of the eye. It results in progressive loss of central vision. Occurring most often among older people, it is the most common cause of vision loss in people over age 55. It is believed that both genetic and environmental factors influence this disease.
111 E 59th St
New York, NY 10022-1202
American Foundation for the Blind
2 Penn Plaza
New York, NY 10121
American Council of the Blind
2200 Wilson Boulevard
Arlington, VA 22201
Association for Macular Diseases, Inc.
210 E. 64th St.
New York, NY 10065
NIH/National Eye Institute
31 Center Dr
Bethesda, MD 20892-2510
American Health Assistance Foundation
22512 Gateway Center Drive
Clarksburg, MD 20871
Eye Cancer Foundation
115 East 61st Street, Suite 5B
New York, NY 10021
MD Support - The Eyes of the Macular Degeneration Community
3600 Blue Ridge Blvd
Grandview, MO 64030
Genetic and Rare Diseases (GARD) Information Center
PO Box 8126
Gaithersburg, MD 20898-8126
Foundation Fighting Blindness (Canada)
890 Yonge Street, 12th Floor
Toronto, Ontario, M4W 3P4
Macular Disease Society
PO Box 1870
Andover, SP10 9AD
For a Complete Report
This is an abstract of a report from the National Organization for Rare Disorders (NORD). A copy of the complete report can be downloaded free from the NORD website for registered users. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational therapies (if available), and references from medical literature. For a full-text version of this topic, go to www.rarediseases.org and click on Rare Disease Database under "Rare Disease Information".
The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only. NORD recommends that affected individuals seek the advice or counsel of their own personal physicians.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report
This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.
For additional information and assistance about rare disorders, please contact the National Organization for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site www.rarediseases.org or email email@example.com
Last Updated: 5/7/2008
Copyright 1986, 1987, 1990, 1996, 1997, 1998, 1999, 2000, 2004 National Organization for Rare Disorders, Inc.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.